Official sources reveal that India has lower rates of MRSA and VRE compared to the US and Europe, despite a significant ...

The National Centre for Disease Control (NCDC) has clarified claims made in a study published in The Lancet, which reported a ...

Infectious diseases researcher at the University of Auckland, associate professor Mark Thomas, told Checkpoint VRE was a ...

The National Centre for Disease Control (NCDC) says the findings of the recent Lancet study reflects bacterial colonisation, ...

VRE is classified as a superbug due to its resistance to vancomycin, making it more difficult to treat than standard bacterial infections. Photo: Peter Meecham / The Press Two small outbreaks ...

A new study reveals India's drug-resistant infection rates are lower than those in the U.S. and Europe, despite microbial ...

There are currently two small outbreaks, of fewer than 10 patients on one ward, with two different strains of vancomycin-resistant enterococci . One strain has been linked to an Auckland cluster.

The NCDC challenged a Lancet study on high MDRO colonisation in Indian ERCP patients, stating colonisation infection and ...

Outbreaks of a drug-resistant superbug have been detected in Auckland and Christchurch hospitals, Health NZ says.

Christchurch Hospital is currently dealing with two small outbreaks of VRE. Fewer than 10 patients are affected on one ward, with two different strains - one has been linked to an Auckland cluster.